Table 4.
IL-10 and IL-18 expression genotypes in UCNT patients and healthy controls in the Italian population
| Cytokine | Genotype | UCNT | Controls |
|---|---|---|---|
| n=89, n(%) | n=130, n(%) | ||
| IL-10a | |||
| GCC/GCC | 19 (21.3) | 26 (20.0) | |
| GCC/ACC | 19 (21.3) | 27 (20.8) | |
| GCC/ATA | 22 (24.7) | 31 (23.8) | |
| ACC/ACC | 10 (11.2) | 17 (13.1) | |
| ACC/ATA | 14 (15.7) | 23 (17.7) | |
| ATA/ATA | 5 (5.6) | 6 (4.6) | |
| IL-18b | |||
| AA/CC | 7 (7.9) | 5 (3.8) | |
| AA/GC | 12 (13.5) | 11 (8.5) | |
| AA/GG | 2 (2.2) | 7 (5.4) | |
| AC/GG | 15 (16.9) | 22 (16.9 | |
| AC/GC | 27 (30.3) | 42 (32.3) | |
| CC/GG | 26 (29.2) | 43 (33.1) | |
a X 25 =0.81 p=0.98
b X 25 =4.41 p=0.49